CARCINOMA, PANCREATIC DUCTAL
Clinical trials for CARCINOMA, PANCREATIC DUCTAL explained in plain language.
Never miss a new study
Get alerted when new CARCINOMA, PANCREATIC DUCTAL trials appear
Sign up with your email to follow new studies for CARCINOMA, PANCREATIC DUCTAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Pfizer's new cancer pill tested in advanced tumors – study halted early
Disease control TerminatedThis early-stage study tested a new cancer pill (PF-07985045) alone or with other drugs in people with advanced solid tumors that have a KRAS gene mutation. The trial included patients with lung, colon, or pancreatic cancer. The study aimed to check safety and find the right dose…
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Pfizer's new cancer drug combo tested in tiny early trial
Disease control TerminatedThis early-stage study tested a new drug called PF-08046037, alone or with another drug (sasanlimab), in 8 people with advanced lung, pancreatic, melanoma, or head & neck cancers. The goal was to check safety and how the body handles the drugs. The trial was terminated early, so …
Matched conditions: CARCINOMA, PANCREATIC DUCTAL
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC